Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,215 across all filing types
Latest filing 2021-12-14 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules. The document is a regulatory disclosure form required by the Stock Exchange of Hong Kong (SEHK) concerning share repurchases and capital changes. It is not a full financial report, earnings release, or management discussion, but a formal notification of share capital changes and repurchases. This fits the definition of a Transaction in Own Shares (POS) filing, which reports the company's buyback or sale of its own shares.
2021-12-14 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON POSSIBLE SPIN-OFF OF JIANGSU BEST NEW MEDICAL
Capital/Financing Update Classification · 95% confidence The document is a voluntary announcement by the board of directors of SSY Group Limited regarding a possible spin-off of a subsidiary, Jiangsu Best New Medical. It discusses regulatory compliance, listing applications, and waivers related to the spin-off process. The document does not contain financial statements, detailed financial data, or a full report but rather provides an update on corporate actions and regulatory matters. It is not a full Annual Report, Interim Report, or Earnings Release. It is also not a proxy statement, voting results, or a management discussion. The document is an announcement about a capital restructuring event (spin-off) and related regulatory approvals and waivers. Therefore, it fits best under Capital/Financing Update (CAP). The document length is sufficient and contains substantive information about the spin-off progress and regulatory compliance, not just a brief notice or report publication announcement. Confidence is high given the clear focus on the spin-off and related regulatory matters.
2021-12-13 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It includes detailed information on repurchases of shares, dates, quantities, prices, and confirmations of compliance with listing rules on the Stock Exchange of Hong Kong. The content is regulatory in nature, reporting share repurchase transactions and capital changes, but it is not a full financial report, earnings release, or management discussion. It is a formal disclosure of share capital changes and repurchases, fitting the category of Transaction in Own Shares (POS). The document length is over 10,000 characters and contains substantive data on share repurchases, not just an announcement or certification, so it is not Regulatory Filings (RNS) or Report Publication Announcement (RPA).
2021-12-10 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings Classification · 95% confidence The document is a detailed monthly report on movements in securities, specifically focusing on changes in authorised and issued share capital, share options, repurchases, and confirmations related to securities issued by SSY Group Limited. It includes specific data on share repurchases and cancellations, share option schemes, and confirmations by the company secretary. The document is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. It is not a full financial report, earnings release, or management discussion, but rather a regulatory filing detailing share capital movements and related confirmations. This fits the description of a Regulatory Filing (RNS) as it is a compliance document reporting share capital changes and confirmations to the exchange, without being a full report or announcement of a report publication.
2021-12-01 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for SSY Group Limited. It includes detailed information on repurchases and cancellations of shares, dates of changes, and confirmations by the board of directors. The content focuses on share repurchase activities and changes in capital structure rather than financial results or management commentary. It is not a full financial report but a regulatory disclosure about share capital changes. This matches the description of a Transaction in Own Shares (POS) filing, which reports company buybacks or sales of its own shares. The document length and detail confirm it is the report itself, not just an announcement or certification.
2021-11-29 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 95% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks by SSY Group Limited. It details repurchases of shares on specific dates, quantities, and prices, confirming compliance with listing rules. The document is a regulatory disclosure about share repurchases and capital changes, not a full financial report or earnings release. It fits the category of a report on the company buying back its own shares (share repurchase/issuance). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length and detail support this classification with high confidence.
2021-11-26 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.